How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Aloxi is given by a doctor or nurse, not picked up at a pharmacy.

What to do

  1. Ask your care team or your plan what you’d pay before your visit.

Your care team and your insurance decide which product you get.

Compare every option

Brand name

Aloxi itself isn’t sold as a prescription anymore.

Not soldNo longer sold

Authorized generic

The same medicine as Aloxi, without the brand name

Cash priceAsk the pharmacyOften less than Aloxi
How to ask for it

The NDC to ask for

The same medicine as Aloxi, without the brand name. Its NDC is the number that names the exact product: give it to the pharmacy and they can look it up or order it.

Sold as

palonosetron

Sold by
  • Cipla

Given by your care team

This is given by IV at a clinic or hospital, usually before chemotherapy. It isn’t picked up at a pharmacy.

  1. NDC (for your care team)

    • 0.25 mg/5 mLinjection
      • 69097-927-35Same number, 11 digits: 69097-0927-355 mL per vial
  2. What to ask your care team

    “Which version of Aloxi do you use: the brand, the authorized generic or a regular generic? What would I pay for each?”

Source: FDA, updated November 16, 2026

Brand and authorized generic labels

Official labels and ingredient lists from DailyMed (U.S. National Library of Medicine).

Aloxi itself isn’t sold anymore, so there’s no current brand label to compare. Here’s the authorized generic’s label.

Authorized genericCipla
See the ingredients

Active: palonosetron hydrochloride 0.25 mg/5 mL

Inactive:

  • Citric acid monohydrate
  • Edetate disodium
  • Mannitol
  • Sodium citrate
  • Water

Regular generic

Same active ingredient as Aloxi. Fillers and dyes can differ.

Cash priceAsk the pharmacyUsually the lowest
Who makes it

Who makes it

11 companies sell an FDA-rated generic of Aloxi. It’s given by your care team, who choose which one to use.

  • ApotexInjection 0.25 mg/5 mL

    Made by Qilu Pharm Hainan

    How it looks, what’s in it, NDCs

    0.25 mg/5 mL

    PackageNDC
    Carton of 5 mL60505-6193-1
    Carton of 50 mL60505-6193-4

    0.25 mg/5 mL

    PackageNDC
    Carton of 5 mL60505-6439-1

    Inactive ingredients: mannitol, citric acid monohydrate, sodium citrate, water

    FDA label

  • BluePoint LaboratoriesSolution 0.05 mg/mL · Injection 0.25 mg/5 mL

    Made by Dr. Reddy’s Laboratories and Qilu Pharm Hainan

    How it looks, what’s in it, NDCs

    0.05 mg/mL

    PackageNDC
    Carton of 5 mL68001-355-25

    0.25 mg/5 mL

    PackageNDC
    Carton of 5 mL68001-708-25

    Inactive ingredients: mannitol, edetate disodium, sodium acetate, water, citric acid monohydrate, sodium citrate form

    FDA label

  • Dr. Reddy’s LaboratoriesSolution 0.05 mg/mL
    How it looks, what’s in it, NDCs

    0.05 mg/mL

    PackageNDC
    Carton of 5 mL55111-694-07
    Carton of 7.5 mL55111-694-19

    Inactive ingredients: mannitol, edetate disodium, sodium acetate, water

    FDA label

  • EugiaSolution 0.25 mg/5 mL

    Product page on eugiaus.com

    How it looks, what’s in it, NDCs

    0.25 mg/5 mL

    PackageNDC
    Carton of 5 mL55150-186-05

    Inactive ingredients: mannitol, edetate disodium, trisodium citrate dihydrate, citric acid monohydrate, hydrochloric acid, sodium hydroxide, water

    FDA label

  • Fresenius KabiSolution 0.25 mg/5 mL

    Product page on fresenius-kabi.com

    How it looks, what’s in it, NDCs

    0.25 mg/5 mL

    PackageNDC
    Carton of 50 mL63323-673-89

    0.25 mg/5 mL

    PackageNDC
    Carton of 5 mL63323-673-05

    Inactive ingredients: mannitol, edetate disodium, trisodium citrate dihydrate, anhydrous citric acid, hydrochloric acid, sodium hydroxide

    FDA label

  • Meitheal PharmaceuticalsSolution 0.25 mg/5 mL

    Product page on meithealpharma.com

    How it looks, what’s in it, NDCs

    0.25 mg/5 mL

    PackageNDC
    Carton of 5 mL71288-409-05

    Inactive ingredients: mannitol, edetate disodium, trisodium citrate dihydrate, citric acid monohydrate, hydrochloric acid, sodium hydroxide, water

    FDA label

  • Mylan InstitutionalSolution 0.25 mg/5 mL
    How it looks, what’s in it, NDCs

    0.25 mg/5 mL

    PackageNDC
    Carton of 5 mL67457-317-25

    Inactive ingredients: mannitol, edetate disodium, citric acid monohydrate, sodium citrate form, water, hydrochloric acid, sodium hydroxide

    FDA label

  • NorthStar RxSolution 0.05 mg/mL

    Made by Dr. Reddy’s Laboratories

    Product page on northstarrxllc.com

    How it looks, what’s in it, NDCs

    0.05 mg/mL

    PackageNDC
    Carton of 5 mL16714-834-01

    Inactive ingredients: mannitol, edetate disodium, sodium acetate, water

    FDA label

  • Sagent PharmaceuticalsSolution 0.05 mg/mL
    How it looks, what’s in it, NDCs

    0.05 mg/mL

    PackageNDC
    Carton of 5 mL25021-783-05

    Inactive ingredients: mannitol, edetate disodium, citric acid monohydrate, water, sodium hydroxide, hydrochloric acid, trisodium citrate dihydrate

    FDA label

  • SandozSolution 0.25 mg/5 mL
    How it looks, what’s in it, NDCs

    0.25 mg/5 mL

    PackageNDC
    Carton of 5 mL0781-3312-75
    Carton of 50 mL0781-3312-95

    Inactive ingredients: mannitol, edetate disodium, trisodium citrate dihydrate, citric acid monohydrate, hydrochloric acid, sodium hydroxide, water

    FDA label

  • Teva Parenteral MedicinesSolution 0.25 mg/5 mL

    Being phased out; sold until December 2026

    How it looks, what’s in it, NDCs

    0.25 mg/5 mL

    PackageNDC
    Carton of 5 mL0703-4094-01

    Inactive ingredients: mannitol, edetate disodium, trisodium citrate dihydrate, citric acid monohydrate, water, hydrochloric acid, sodium hydroxide

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What it’s used for

What the FDA label says

Palonosetron Hydrochloride Injection is a serotonin-3 (5-HT3) receptor antagonist indicated in adults for:

  • Moderately emetogenic cancer chemotherapy - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses
  • Highly emetogenic cancer chemotherapy - prevention of acute nausea and vomiting associated with initial and repeat courses
  • Prevention of postoperative nausea and vomiting (PONV) for up to 24 hours following surgery. Efficacy beyond 24 hours has not been demonstrated

Palonosetron Hydrochloride Injection is indicated in pediatric patients aged 1 month to less than 17 years for:

  • Prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy

Source: the FDA label for palonosetron hydrochloride (Cipla USA Inc.), January 13, 2022. Full label on DailyMed 

Good to know

  • It may look different from Aloxi (color, shape, or markings). That’s normal for an authorized generic.
  • If your prescription says “dispense as written,” the pharmacy needs your prescriber’s OK to give you the authorized generic.
  • Coverage depends on your plan. Your care team or insurer can tell you what you’d pay.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.